Healthcare - Biotechnology - NASDAQ - GB
$ 3.62
-25.9 %
$ 2.1 M
Market Cap
-0.05
P/E
CASH FLOW STATEMENT
-6.83 M
OPERATING CASH FLOW
-265 K
INVESTING CASH FLOW
10.2 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Biodexa Pharmaceuticals Plc
| Net Income | -7.08 M |
| Depreciation & Amortization | 283 K |
| Capital Expenditures | -263 K |
| Stock-Based Compensation | 28 K |
| Change in Working Capital | -49 K |
| Others | -17 K |
| Free Cash Flow | -7.09 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (7.1) | (7.7) | (5.5) | (22.2) | (10.1) | (15.0) | (16.1) | (20.2) | (10.1) | (8.8) | (4.1) | (4.0) |
| Depreciation & Amortization | 0.3 | 0.3 | 0.4 | 1.2 | 1.3 | 1.1 | 1.2 | 4.3 | 0.7 | 0.3 | 0.2 | 0.2 |
| Deferred Income Tax | (0.4) | (0.8) | 0.5 | 13.2 | (1.8) | 0 | 0 | 0 | 1.4 | 0 | 0 | 0 |
| Stock Based Compensation | 28 K | 0.1 | 89 K | (0.4) | 34 K | 0 | 0 | 0 | 0.2 | 0 | 0 | 0 |
| Other Operating Activities | 0.4 | 0.5 | (0.9) | 0.4 | 2.3 | (1.1) | 3.1 | 3.2 | (1.6) | 2.3 | (0.2) | 0.6 |
| Change in Working Capital | 49 K | 0.5 | (0.6) | (1.6) | 1.8 | 1.5 | (1.2) | (0.5) | (1.6) | 0.8 | (0.4) | (0.2) |
| Cash From Operations | (6.8) | (7.0) | (6.0) | (9.3) | (6.5) | (13.4) | (13.0) | (13.1) | (12.4) | (5.5) | (4.4) | (3.2) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (0.3) | 62 K | (0.3) | (0.2) | (0.3) | (0.2) | (0.7) | (1.3) | (0.9) | (1.0) | 47 K | (0.2) |
| Other Items | 2 K | (0.2) | 42 K | 2.8 | (3.5) | 9.3 | (0.8) | 0.1 | (0.6) | 0.1 | 3 K | 59 K |
| Cash From Investing Activities | (0.3) | (0.2) | (0.3) | 2.6 | (3.8) | 9.0 | (1.5) | (1.2) | (1.5) | (0.9) | 50 K | (0.3) |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (0.2) | (0.2) | (0.2) | (6.2) | 3.9 | (5.9) | 4.7 | (0.2) | (0.2) | 0.5 | 1.1 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 13 K | 18 K | 15 K | (0.5) | 0.8 | (0.6) | (0.1) | 15.5 | 5 K | 96 K | (0.1) | (0.1) |
| Cash From Financing Activities | 10.2 | 47 K | 8.8 | 3.1 | 18.7 | (6.5) | 10.3 | 15.3 | (0.2) | 34.3 | 6.7 | (0.1) |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 3.1 | (7.2) | 2.5 | (3.4) | 8.6 | (10.9) | (4.4) | 1.4 | (14.2) | 27.9 | 2.3 | 0.1 |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (7.1) | (7.1) | (6.3) | (9.5) | (6.8) | (13.7) | (13.7) | (14.4) | (13.3) | (6.5) | (4.5) | (3.5) |